EX-99.1 3 f76314ex99-1.htm PRO FORMA BALANCE SHEET AS OF JUNE 30, 2001 Pro Forma Balance Sheet as of June 30, 2001
 

EXHIBIT 99.1

The condensed consolidated balance sheets of Critical Path, Inc. reflect the actual audited condensed consolidated balance sheet as of December 31, 2000, the actual unaudited condensed consolidated balance sheet as of June 30, 2001 and the unaudited condensed consolidated pro forma balance sheet as of June 30, 2001. The pro forma balance sheet reflects certain adjustments related to the repurchase of $192 million of face value of its outstanding convertible subordinated notes, which occurred during the third quarter of 2001, as if the purchases had occurred on June 30, 2001.

In aggregate the pro forma balance sheet reflects cash paid of $50.7 million in principle and accrued interest and includes the affects of the reduction in cash related to the payment of principal of approximately $47.9 million and accrued interest of approximately $2.8 million and the elimination of the related outstanding principle of approximately $192.0 million and accrued interest of approximately $2.8 million. At June 30, 2001 unamortized debt issuance costs for Critical Path were approximately $8.2 million, and accordingly the pro forma balance sheet reflects a $5.4  million adjustment to write down the debt issuance costs related to the portion of the notes, which were repurchased. The repurchase of $192 million of face value of its outstanding convertible subordinated notes resulted in a significant net gain, and accordingly the pro forma balance sheet reflects an adjustment to shareholders' equity of approximately $138.7 million in extraordinary gain.

CRITICAL PATH, INC.
Condensed Consolidated Balance Sheets
(Unaudited)
(In thousands)

                             
        Actual   Actual     Pro Forma
        December 31,   June 30,     June 30,
        2000   2001     2001
       
 
 
      (Unaudited)
ASSETS
Current assets
                       
 
Cash, cash equivalents and short-term investments
  $ 216,542     $ 132,586     $ 81,890  
 
Restricted cash
    215       1,032       1,032  
 
Accounts receivable, net
    38,938       29,437       29,437  
 
Other current assets
    10,252       6,997       6,997  
 
   
     
     
 
   
Total current assets
    265,947       170,052       119,356  
Long-term investments
    10,610       8,349       8,349  
Notes receivable from officers
    2,702       2,370       2,370  
Property and equipment, net
    85,304       73,000       73,000  
Intangible assets, net
    77,339       44,298       44,298  
Other assets
    8,953       9,298       3,886  
 
   
     
     
 
   
Total assets
  $ 450,855     $ 307,367     $ 251,259  
 
   
     
     
 
LIABILITIES AND SHAREHOLDERS’ EQUITY (DEFICIT)
Current liabilities
                       
 
Accounts payable
  $ 43,710     $ 34,059     $ 31,296  
 
Accrued expenses
    10,377       7,645       7,645  
 
Deferred revenue
    15,720       15,593       15,593  
 
Capital lease and other obligations, current
    9,363       6,899       6,899  
 
   
     
     
 
   
Total current liabilities
    79,170       64,196       61,433  
Convertible subordinated notes payable
    300,000       295,000       102,990  
Capital lease and other obligations, long-term
    4,687       2,303       2,303  
 
   
     
     
 
   
Total liabilities
    383,857       361,499       166,726  
 
   
     
     
 
Commitments and contingencies
Minority interest in consolidated subsidiary
    649              
 
   
     
     
 
Shareholders’ Equity (Deficit)
    66,349       (54,132 )     84,533  
 
   
     
     
 
   
Total liabilities and shareholders’ equity (deficit)
  $ 450,855     $ 307,367     $ 251,259